 | • レポートコード：QYR9ST04930 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、大うつ病性障害（MDD）の世界市場について調査・分析し、大うつ病性障害（MDD）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗うつ薬、SSRI、SNRI、ベンゾジアゼピン、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の大うつ病性障害（MDD）市場動向 ・主要企業別マーケットシェア ・大うつ病性障害（MDD）の種類別市場規模2014-2019 （抗うつ薬、SSRI、SNRI、ベンゾジアゼピン、その他） ・大うつ病性障害（MDD）の用途別市場規模2014-2019 （病院、診療所、その他） ・大うつ病性障害（MDD）の北米市場：主要企業・種類別/用途別市場規模 ・大うつ病性障害（MDD）のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・大うつ病性障害（MDD）の中国市場：主要企業・種類別/用途別市場規模 ・大うつ病性障害（MDD）の日本国内市場：主要企業・種類別/用途別市場規模 ・大うつ病性障害（MDD）の東南アジア市場：主要企業・種類別/用途別市場規模 ・大うつ病性障害（MDD）のインド市場：主要企業・種類別/用途別市場規模 ・大うつ病性障害（MDD）の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、GlaxoSmithKline、Merck、AstraZeneca、Eli Lily、Johnson & Johnson、Forest Laboratories、Sanofi-Aventis、H. Lundbeck、Bristol-Myers Squibb） ・大うつ病性障害（MDD）の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Major Depressive Disorder (MDD) is a common mental illness characterized by persistent low mood that interferes with the person’s ability to eat, work, sleep and other activities. MDD is also referred to as clinical depression or recurrent depression. The common symptoms of this mental disorder are insomnia, loss of interest, recurrent thoughts of death, feelings of worthlessness and reduced ability to think. The rising prevalence of major depression has led to a sharp increase in the patient volume suffering from depression. Currently, many treatments and therapies are available for major depression but the market still holds a large scope of growth opportunities with high unmet needs of the market.The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.
In 2018, the global Major Depressive Disorder (MDD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Major Depressive Disorder (MDD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Major Depressive Disorder (MDD) development in United States, Europe and China.
The key players covered in this study
Pfizer
GlaxoSmithKline
Merck
AstraZeneca
Eli Lily
Johnson & Johnson
Forest Laboratories
Sanofi-Aventis
H. Lundbeck
Bristol-Myers Squibb
Market segment by Type, the product can be split into
Antidepressant Drugs
SSRIs
SNRIs
Benzodiazepines
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Major Depressive Disorder (MDD) status, future forecast, growth opportunity, key market and key players.
To present the Major Depressive Disorder (MDD) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Major Depressive Disorder (MDD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type (2014-2025)
1.4.2 Antidepressant Drugs
1.4.3 SSRIs
1.4.4 SNRIs
1.4.5 Benzodiazepines
1.4.6 Others
1.5 Market by Application
1.5.1 Global Major Depressive Disorder (MDD) Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Major Depressive Disorder (MDD) Market Size
2.2 Major Depressive Disorder (MDD) Growth Trends by Regions
2.2.1 Major Depressive Disorder (MDD) Market Size by Regions (2014-2025)
2.2.2 Major Depressive Disorder (MDD) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Major Depressive Disorder (MDD) Market Size by Manufacturers
3.1.1 Global Major Depressive Disorder (MDD) Revenue by Manufacturers (2014-2019)
3.1.2 Global Major Depressive Disorder (MDD) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Major Depressive Disorder (MDD) Market Concentration Ratio (CR5 and HHI)
3.2 Major Depressive Disorder (MDD) Key Players Head office and Area Served
3.3 Key Players Major Depressive Disorder (MDD) Product/Solution/Service
3.4 Date of Enter into Major Depressive Disorder (MDD) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Major Depressive Disorder (MDD) Market Size by Type (2014-2019)
4.2 Global Major Depressive Disorder (MDD) Market Size by Application (2014-2019)
5 United States
5.1 United States Major Depressive Disorder (MDD) Market Size (2014-2019)
5.2 Major Depressive Disorder (MDD) Key Players in United States
5.3 United States Major Depressive Disorder (MDD) Market Size by Type
5.4 United States Major Depressive Disorder (MDD) Market Size by Application
6 Europe
6.1 Europe Major Depressive Disorder (MDD) Market Size (2014-2019)
6.2 Major Depressive Disorder (MDD) Key Players in Europe
6.3 Europe Major Depressive Disorder (MDD) Market Size by Type
6.4 Europe Major Depressive Disorder (MDD) Market Size by Application
7 China
7.1 China Major Depressive Disorder (MDD) Market Size (2014-2019)
7.2 Major Depressive Disorder (MDD) Key Players in China
7.3 China Major Depressive Disorder (MDD) Market Size by Type
7.4 China Major Depressive Disorder (MDD) Market Size by Application
8 Japan
8.1 Japan Major Depressive Disorder (MDD) Market Size (2014-2019)
8.2 Major Depressive Disorder (MDD) Key Players in Japan
8.3 Japan Major Depressive Disorder (MDD) Market Size by Type
8.4 Japan Major Depressive Disorder (MDD) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Major Depressive Disorder (MDD) Market Size (2014-2019)
9.2 Major Depressive Disorder (MDD) Key Players in Southeast Asia
9.3 Southeast Asia Major Depressive Disorder (MDD) Market Size by Type
9.4 Southeast Asia Major Depressive Disorder (MDD) Market Size by Application
10 India
10.1 India Major Depressive Disorder (MDD) Market Size (2014-2019)
10.2 Major Depressive Disorder (MDD) Key Players in India
10.3 India Major Depressive Disorder (MDD) Market Size by Type
10.4 India Major Depressive Disorder (MDD) Market Size by Application
11 Central & South America
11.1 Central & South America Major Depressive Disorder (MDD) Market Size (2014-2019)
11.2 Major Depressive Disorder (MDD) Key Players in Central & South America
11.3 Central & South America Major Depressive Disorder (MDD) Market Size by Type
11.4 Central & South America Major Depressive Disorder (MDD) Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Major Depressive Disorder (MDD) Introduction
12.1.4 Pfizer Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Major Depressive Disorder (MDD) Introduction
12.2.4 GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Major Depressive Disorder (MDD) Introduction
12.3.4 Merck Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.3.5 Merck Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Major Depressive Disorder (MDD) Introduction
12.4.4 AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.4.5 AstraZeneca Recent Development
12.5 Eli Lily
12.5.1 Eli Lily Company Details
12.5.2 Company Description and Business Overview
12.5.3 Major Depressive Disorder (MDD) Introduction
12.5.4 Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.5.5 Eli Lily Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Major Depressive Disorder (MDD) Introduction
12.6.4 Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.6.5 Johnson & Johnson Recent Development
12.7 Forest Laboratories
12.7.1 Forest Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Major Depressive Disorder (MDD) Introduction
12.7.4 Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.7.5 Forest Laboratories Recent Development
12.8 Sanofi-Aventis
12.8.1 Sanofi-Aventis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Major Depressive Disorder (MDD) Introduction
12.8.4 Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.8.5 Sanofi-Aventis Recent Development
12.9 H. Lundbeck
12.9.1 H. Lundbeck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Major Depressive Disorder (MDD) Introduction
12.9.4 H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.9.5 H. Lundbeck Recent Development
12.10 Bristol-Myers Squibb
12.10.1 Bristol-Myers Squibb Company Details
12.10.2 Company Description and Business Overview
12.10.3 Major Depressive Disorder (MDD) Introduction
12.10.4 Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2014-2019)
12.10.5 Bristol-Myers Squibb Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Major Depressive Disorder (MDD) Key Market Segments
Table Key Players Major Depressive Disorder (MDD) Covered
Table Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Major Depressive Disorder (MDD) Market Size Market Share by Type 2014-2025
Figure Antidepressant Drugs Figures
Table Key Players of Antidepressant Drugs
Figure SSRIs Figures
Table Key Players of SSRIs
Figure SNRIs Figures
Table Key Players of SNRIs
Figure Benzodiazepines Figures
Table Key Players of Benzodiazepines
Figure Others Figures
Table Key Players of Others
Table Global Major Depressive Disorder (MDD) Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Major Depressive Disorder (MDD) Report Years Considered
Table Global Major Depressive Disorder (MDD) Market Size 2014-2025 (Million US$)
Figure Global Major Depressive Disorder (MDD) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Major Depressive Disorder (MDD) Market Size by Regions 2014-2025 (Million US$)
Table Global Major Depressive Disorder (MDD) Market Size by Regions 2014-2019 (Million US$)
Table Global Major Depressive Disorder (MDD) Market Share by Regions 2014-2019
Figure Global Major Depressive Disorder (MDD) Market Share by Regions 2014-2019
Figure Global Major Depressive Disorder (MDD) Market Share by Regions 2019
Table Market Top Trends
Table Global Major Depressive Disorder (MDD) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Major Depressive Disorder (MDD) Market Share by Manufacturers (2014-2019)
Figure Global Major Depressive Disorder (MDD) Market Share by Manufacturers in 2018
Table Global Major Depressive Disorder (MDD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Major Depressive Disorder (MDD) Product/Solution/Service
Table Date of Enter into Major Depressive Disorder (MDD) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Major Depressive Disorder (MDD) Market Size by Type (2014-2019) (Million US$)
Table Global Major Depressive Disorder (MDD) Market Size Share by Type (2014-2019)
Figure Global Major Depressive Disorder (MDD) Market Size Market Share by Type (2014-2019)
Table Global Major Depressive Disorder (MDD) Market Size by Application (2014-2019) (Million US$)
Table Global Major Depressive Disorder (MDD) Market Size Share by Application (2014-2019)
Figure Global Major Depressive Disorder (MDD) Market Size Market Share by Application (2014-2019)
Figure Global Major Depressive Disorder (MDD) Revenue Market Share by Application in 2018
Figure United States Major Depressive Disorder (MDD) Market Size 2014-2019 (Million US$)
Table United States Key Players Major Depressive Disorder (MDD) Revenue (2018-2019) (Million US$)
Table United States Key Players Major Depressive Disorder (MDD) Market Share (2018-2019)
Table United States Major Depressive Disorder (MDD) Market Size by Type (2014-2019) (Million US$)
Table United States Major Depressive Disorder (MDD) Market Share by Type (2014-2019)
Table United States Major Depressive Disorder (MDD) Market Size by Application (2014-2019) (Million US$)
Table United States Major Depressive Disorder (MDD) Market Share by Application (2014-2019)
Figure Europe Major Depressive Disorder (MDD) Market Size 2014-2019 (Million US$)
Table Europe Key Players Major Depressive Disorder (MDD) Revenue (2018-2019) (Million US$)
Table Europe Key Players Major Depressive Disorder (MDD) Market Share (2018-2019)
Table Europe Major Depressive Disorder (MDD) Market Size by Type (2014-2019) (Million US$)
Table Europe Major Depressive Disorder (MDD) Market Share by Type (2014-2019)
Table Europe Major Depressive Disorder (MDD) Market Size by Application (2014-2019) (Million US$)
Table Europe Major Depressive Disorder (MDD) Market Share by Application (2014-2019)
Figure China Major Depressive Disorder (MDD) Market Size 2014-2019 (Million US$)
Table China Key Players Major Depressive Disorder (MDD) Revenue (2018-2019) (Million US$)
Table China Key Players Major Depressive Disorder (MDD) Market Share (2018-2019)
Table China Major Depressive Disorder (MDD) Market Size by Type (2014-20189) (Million US$)
Table China Major Depressive Disorder (MDD) Market Share by Type (2014-2019)
Table China Major Depressive Disorder (MDD) Market Size by Application (2014-2019) (Million US$)
Table China Major Depressive Disorder (MDD) Market Share by Application (2014-2019)
Figure Japan Major Depressive Disorder (MDD) Market Size 2014-2019 (Million US$)
Table Japan Key Players Major Depressive Disorder (MDD) Revenue (2018-2019) (Million US$)
Table Japan Key Players Major Depressive Disorder (MDD) Market Share (2018-2019)
Table Japan Major Depressive Disorder (MDD) Market Size by Type (2014-2019) (Million US$)
Table Japan Major Depressive Disorder (MDD) Market Share by Type (2014-2019)
Table Japan Major Depressive Disorder (MDD) Market Size by Application (2014-2019) (Million US$)
Table Japan Major Depressive Disorder (MDD) Market Share by Application (2014-2019)
Figure Southeast Asia Major Depressive Disorder (MDD) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Major Depressive Disorder (MDD) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Major Depressive Disorder (MDD) Market Share (2018-2019)
Table Southeast Asia Major Depressive Disorder (MDD) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Major Depressive Disorder (MDD) Market Share by Type (2014-2019)
Table Southeast Asia Major Depressive Disorder (MDD) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Major Depressive Disorder (MDD) Market Share by Application (2014-2019)
Figure India Major Depressive Disorder (MDD) Market Size 2014-2019 (Million US$)
Table India Key Players Major Depressive Disorder (MDD) Revenue (2018-2019) (Million US$)
Table India Key Players Major Depressive Disorder (MDD) Market Share (2018-2019)
Table India Major Depressive Disorder (MDD) Market Size by Type (2014-2019) (Million US$)
Table India Major Depressive Disorder (MDD) Market Share by Type (2014-2019)
Table India Major Depressive Disorder (MDD) Market Size by Application (2014-2019) (Million US$)
Table India Major Depressive Disorder (MDD) Market Share by Application (2014-2019)
Figure Central & South America Major Depressive Disorder (MDD) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Major Depressive Disorder (MDD) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Major Depressive Disorder (MDD) Market Share (2018-2019)
Table Central & South America Major Depressive Disorder (MDD) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Major Depressive Disorder (MDD) Market Share by Type (2014-2019)
Table Central & South America Major Depressive Disorder (MDD) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Major Depressive Disorder (MDD) Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Major Depressive Disorder (MDD) Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Major Depressive Disorder (MDD) Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table Merck Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table AstraZeneca Recent Development
Table Eli Lily Company Details
Table Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2014-2019)(Million US$)
Figure Eli Lily Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table Eli Lily Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Forest Laboratories Company Details
Table Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2014-2019)(Million US$)
Figure Forest Laboratories Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table Forest Laboratories Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2014-2019)(Million US$)
Figure Sanofi-Aventis Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table Sanofi-Aventis Recent Development
Table H. Lundbeck Company Details
Table H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2014-2019)(Million US$)
Figure H. Lundbeck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table H. Lundbeck Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Global Major Depressive Disorder (MDD) Market Size by Regions (Million US$) 2019-2025
Figure Global Major Depressive Disorder (MDD) Market Size Share by Regions (2019-2025)
Figure Global Major Depressive Disorder (MDD) Market Size Share by Regions in 2025
Figure United States Major Depressive Disorder (MDD) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Major Depressive Disorder (MDD) Market Size Forecast (2019-2025)(Million USD)
Figure China Major Depressive Disorder (MDD) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Major Depressive Disorder (MDD) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Major Depressive Disorder (MDD) Market Size Forecast (2019-2025)(Million USD)
Figure India Major Depressive Disorder (MDD) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Major Depressive Disorder (MDD) Market Size Forecast (2019-2025)(Million USD)
Table Global Major Depressive Disorder (MDD) Market Size by Product (2019-2025) (Million US$)
Figure Global Major Depressive Disorder (MDD) Market Size by Product (2019-2025)
Figure Global Major Depressive Disorder (MDD) Market Size by Product in 2025
Table Global Major Depressive Disorder (MDD) Market Size by Application (2019-2025) (Million US$)
Figure Global Major Depressive Disorder (MDD) Market Size by Application (2019-2025)
Figure Global Major Depressive Disorder (MDD) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
抗うつ薬の世界市場：インサイト・予測 Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps i…- 双極性障害の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity le…
- 世界の季節性情動障害治療薬市場：専門的調査 Seasonal affective disorder or SAD is a recurrent major depressive disorder with a seasonal pattern usually beginning in fall and continuing into winter months. The global Seasonal Affective Disorder Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, …
- 双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…
- 甲状腺障害の世界市場：市場規模・現状・予測 Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of …